A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...
Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback